639 results on '"VAN CALSTEREN, KRISTEL"'
Search Results
2. Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology
3. Interventional radiology for prevention and management of postpartum haemorrhage: a single centre retrospective cohort study
4. Child outcomes after prenatal exposure to platinum and taxane-based chemotherapy: an unplanned interim analysis of the international network on cancer, infertility, and pregnancy study
5. Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy
6. Cell-free DNA methylome analysis for early preeclampsia prediction
7. Long-term neurocognitive, psychosocial, and physical outcomes after prenatal exposure to radiotherapy: a multicentre cohort study of the International Network on Cancer, Infertility, and Pregnancy
8. Reassuring pregnancy outcomes in women with mild COL4A3-5–related disease (Alport syndrome) and genetic type of disease can aid personalized counseling
9. Rare autosomal trisomies detected by non-invasive prenatal testing: an overview of current knowledge
10. Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?
11. Ten-year experience of a national multidisciplinary tumour board for cancer and pregnancy in the Netherlands
12. Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controls
13. Development and design of the BELpREG registration system for the collection of real-world data on medication use in pregnancy and mother-infant outcomes.
14. Maternal death by cancer in pregnancy: A descriptive study of the International Network on Cancer, Infertility and Pregnancy.
15. Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets
16. Enhancing the value of the sFlt-1/PlGF ratio for the prediction of preeclampsia: Cost analysis from the Belgian healthcare payers’ perspective
17. Impact of a blended learning program on community pharmacists’ barriers, knowledge, and counseling practice with regard to preconception, pregnancy and lactation
18. Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies
19. Renal and Bladder Cancer During Pregnancy: A Review of 47 Cases and Literature-based Recommendations for Management
20. A comprehensive review on non-clinical methods to study transfer of medication into breast milk – A contribution from the ConcePTION project
21. Comparison of risk stratification models for pregnancy in congenital heart disease
22. Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP)
23. Cardiac interventions in pregnancy and peripartum – a narrative review of the literature
24. Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy
25. Community pharmacists’ attitudes, barriers, knowledge and counseling practice with regard to preconception, pregnancy and lactation
26. Arabic-speaking pregnant women with a migration background: A vulnerable target group for prenatal counseling on medicines
27. Determining the exposure of maternal medicines through breastfeeding: the UmbrelLACT study protocol—a contribution from the ConcePTION project
28. Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study
29. Reassuring pregnancy outcomes in women with mild COL4A3-5 related disease (Alport Syndrome) as the genetic type of disease can aid personalized counseling.
30. Pushing the boundaries. Concurrent Hodgkin lymphoma and breast cancer treatment with preservation of pregnancy: A case report
31. Long-term neurocognitive, psychosocial, and physical outcomes after prenatal exposure to radiotherapy: a multicentre cohort study of the International Network on Cancer, Infertility, and Pregnancy
32. Determining the exposure of maternal medicines through breastfeeding:the UmbrelLACT study protocol - a contribution from the ConcePTION project
33. Integration of Placental Transfer in a Fetal–Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus
34. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study
35. Long-term impact of prenatal exposure to chemotherapy on executive functioning: An ERP study
36. Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model
37. Results of an international survey on the current organization of care for pregnant women with cancer
38. Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real‐world data source on medication use in pregnancy in Belgium
39. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients
40. Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women
41. Beliefs about medicines and information needs among pregnant women visiting a tertiary hospital in Belgium
42. Breast Cancer (Diagnosed) During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients
43. Supplementary Tables 1 from Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features
44. Data from Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features
45. Supplementary Figures 1 from Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features
46. What helps define outcomes in persistent uninterpretable non‐invasive prenatal testing: Maternal factors, fetal fraction or quality scores?
47. Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features
48. Integration and validation of the ex vivo human placenta perfusion model
49. Ovarian cancer in pregnancy
50. Pregnancy and Cancer: the INCIP Project
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.